Product Name:

NebuPeptide™ Triptorelin (Peptide Reference)

Catalog Number:

NBS-233779

Description:

NebuPeptide™ Triptorelin (Peptide Reference)(CAT#NBS-233779) is synthesized in accordance with the Triptorelin sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Insulin degludec/Liraglutide reference peptide ranging from milligrams to kilograms.

Peptide Name:

Triptorelin

Background:

Triptorelin is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. It is also used as therapy in cases of gender dysphoria.

Alias:

Triptoreline; Arvekap; Triptorelina

CAS Number:

57773-63-4

Formula:

C64H82N18O13

Molecular Weight:

1311.44868

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

For R&D use only!

To get more information, please contact us freely.